vimarsana.com
Home
Live Updates
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer - PDS Biotechnology (NASDAQ:PDSB) : vimarsana.com
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer - PDS Biotechnology (NASDAQ:PDSB)
PRINCETON, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or "the Company"), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer
Related Keywords
United States ,
Gina Cestari ,
Laurenv Wood ,
Frank Bedu ,
Kirk Shepard ,
Kirkv Shepard ,
University Of Cincinnati Medical School ,
Global Medical Affairs At Takeda Pharmaceuticals International ,
Department Of Hematology ,
Biotechnology Corporation The Company ,
Global Medical Affairs At Baxter International Inc ,
Exchange Commission ,
Scientific Affairs At Boehringer Ingelheim Pharmaceuticals Inc ,
Twitter ,
Biotechnology Corporation ,
Case Western Reserve University ,
Cornell University ,
Merck Co Inc ,
Affairs Professional Society ,
Cleveland Clinic Foundation ,
University Of Chicago Hospitals ,
United States Securities Exchange ,
Chief Medical Officer ,
Frank Bedu Addo ,
Chief Executive Officer ,
Senior Vice President ,
Global Medical Affairs Oncology Business Group ,
Eisai Pharmaceutical ,
Medical Affairs Professional Society ,
Global Medical Affairs ,
Baxter International Inc ,
Takeda Pharmaceuticals International ,
Vice President ,
Scientific Affairs ,
Boehringer Ingelheim Pharmaceuticals ,
Medical Oncology ,
Cincinnati Medical ,
Chicago Hospitals ,
Nasdaq Listing Rule ,
United States Securities Exchange Act ,
United States Securities Act ,
Financial Condition ,
Merck Sharp ,
vimarsana.com © 2020. All Rights Reserved.